Inclusive of all taxes
Recombinant Human Erythropoietin Alfa Injection is a sterile, injectable formulation designed specifically for the treatment of anemia caused by chronic kidney disease (CKD) and chemotherapy-induced anemia. This biopharmaceutical product contains recombinant erythropoietin, a glycoprotein hormone analog that stimulates erythropoiesis, the production of red blood cells in the bone marrow. By effectively increasing hemoglobin levels, this injection helps reduce the need for blood transfusions and improves the quality of life in patients suffering from anemia related to CKD and chemotherapy treatments. The product is manufactured under stringent quality controls ensuring purity, potency, and safety for clinical use in hospitals and specialized treatment centers.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Recombinant Human Erythropoietin Alfa |
| Indications | Treatment of anemia associated with chronic kidney disease and chemotherapy-induced anemia |
| Formulation | Injectable solution |
| Administration Route | Intravenous or subcutaneous injection |
| Mechanism of Action | Stimulates erythropoiesis to increase red blood cell production |
| Dosage Form | Pre-filled syringes or vials |
| Purity and Quality | Manufactured under high-quality sterile conditions |
| Packaging | Available in single-use sterile vials or syringes |
| Shelf Life | Typically 24 months when stored as recommended |
| Storage Conditions | Refrigerated storage between 2°C to 8°C |
| Attributes | Description |
|---|---|
| Molecular Type | Recombinant glycoprotein |
| Concentration | Variable depending on vial strength, commonly 2000 IU/ml to 40,000 IU/ml |
| pH Range | Approximately 6.8 to 7.5 |
| Packaging Size | 1 ml, 1.5 ml or 10 ml vials or pre-filled syringes |
| Preservatives | Typically preservative-free or with minimal preservative suitable for injection |
| Manufacturing Compliance | Produced in GMP-certified facilities |
| Storage Temperature | 2°C to 8°C (Refrigerated) |
| Shelf Life | 24 months from the date of manufacture |
| Compatibility | Compatible with intravenous and subcutaneous administration |
| Regulatory Approval | Complies with CDSCO guidelines for biopharmaceutical injections |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
This injection is primarily indicated for treating anemia due to chronic kidney disease and chemotherapy-induced anemia.
The injection is administered either intravenously or subcutaneously as prescribed by the healthcare provider.
It should be stored refrigerated between 2°C to 8°C and protected from freezing.
Yes, it complies with CDSCO guidelines and must be manufactured in GMP-certified facilities with valid regulatory approvals.
The injection is commonly available in concentrations ranging from 2000 IU/ml up to 40,000 IU/ml in various vial or pre-filled syringe sizes.
Country Of Origin: India
Recombinant Human Erythropoietin Alfa is used in the treatment of anemia due to chronic kidney disease and anemia due to chemotherapy.
Inclusive of all taxes
You Save: 0
